Literature DB >> 18197992

Consumption of fructo-oligosaccharide reduces 2,4-dinitrofluorobenzene-induced contact hypersensitivity in mice.

Jun Watanabe1, Naho Sasajima, Akiko Aramaki, Kei Sonoyama.   

Abstract

Strategies to manipulate the intestinal microbiota have been considered to promote immune health. The aim of the present study was to examine whether fructo-oligosaccharide, a typical prebiotic, could suppress antigen-specific skin inflammation by favourably changing the population of intestinal microbiota. Female BALB/c mice were fed a synthetic diet with or without fructo-oligosaccharide supplementation for 3 weeks and were then epicutaneously immunised with 2,4-dinitrofluorobenzene. Afterwards, mice continued to receive their respective diets. At 5 d after immunisation, the mice were ear challenged with the hapten. Ear swelling after the challenge was significantly reduced in the mice fed the diet supplemented with fructo-oligosaccharide than in mice fed the control diet. To characterise the change in the intestinal microbiota, DNA samples isolated from fresh faeces were subjected to PCR-denaturing gradient gel electrophoresis and real-time PCR based on 16S rDNA gene sequences. Dietary fructo-oligosaccharide altered the composition of intestinal microbiota. The numbers of bifidobacteria, but not lactobacilli, were significantly higher in mice fed the fructo-oligosaccharide-supplemented diet than in mice fed the control diet. Ear swelling was negatively correlated with the numbers of bifidobacteria in the faeces. Sequence analysis revealed that Bifidobacterium pseudolongum was the most predominant bifidobacteria in the intestine of mice fed the fructo-oligosaccharide-supplemented diet. These results suggest that consumption of fructo-oligosaccharide reduces contact hypersensitivity, which is associated with proliferation of B. pseudolongum in the intestinal tract of mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197992     DOI: 10.1017/S0007114507901221

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  7 in total

1.  Dietary soyasaponin attenuates 2,4-dinitrofluorobenzene-induced contact hypersensitivity via gut microbiota in mice.

Authors:  T Nagano; M Katase; K Tsumura
Journal:  Clin Exp Immunol       Date:  2018-10-07       Impact factor: 4.330

Review 2.  The interplay between fiber and the intestinal microbiome in the inflammatory response.

Authors:  Shiu-Ming Kuo
Journal:  Adv Nutr       Date:  2013-01-01       Impact factor: 8.701

3.  Short-chain fatty acids and inulin, but not guar gum, prevent diet-induced obesity and insulin resistance through differential mechanisms in mice.

Authors:  Karolin Weitkunat; Christin Stuhlmann; Anna Postel; Sandra Rumberger; Maria Fankhänel; Anni Woting; Klaus Jürgen Petzke; Sabrina Gohlke; Tim J Schulz; Michael Blaut; Susanne Klaus; Sara Schumann
Journal:  Sci Rep       Date:  2017-07-21       Impact factor: 4.379

4.  Fructo-Oligosaccharide Alleviates Soybean-Induced Anaphylaxis in Piglets by Modulating Gut Microbes.

Authors:  Meinan Chang; Yuan Zhao; Guixin Qin; Xiaodong Zhang
Journal:  Front Microbiol       Date:  2018-11-20       Impact factor: 5.640

Review 5.  Prebiotics: Mechanisms and Preventive Effects in Allergy.

Authors:  Carole Brosseau; Amandine Selle; Debra J Palmer; Susan L Prescott; Sébastien Barbarot; Marie Bodinier
Journal:  Nutrients       Date:  2019-08-08       Impact factor: 5.717

6.  Persistence of orally administered lactobacillus strains in the gut of infant mice.

Authors:  Keisuke Ozawa; Reiko Fujiwara; Karin Watanabe; Kei Sonoyama
Journal:  Biosci Microbiota Food Health       Date:  2012-10-25

7.  Inverse association between estrogen receptor-α DNA methylation and breast composition in adolescent Chilean girls.

Authors:  Alexandra M Binder; Leah T Stiemsma; Kristen Keller; Sanne D van Otterdijk; Verónica Mericq; Ana Pereira; José L Santos; John Shepherd; Karin B Michels
Journal:  Clin Epigenetics       Date:  2018-10-04       Impact factor: 6.551

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.